Return On Equity in % of CITIUS ONCOLOGY, INC. from 2022 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CITIUS ONCOLOGY, INC. quarterly/annual Return On Equity history and change rate from 2022 to Q2 2025.
  • CITIUS ONCOLOGY, INC. Return On Equity for the quarter ending 30 Jun 2025 was -68.4 %, a 2.66% decline year-over-year.
  • CITIUS ONCOLOGY, INC. annual Return On Equity for 2024 was -80 %, a 501% decline from 2023.
  • CITIUS ONCOLOGY, INC. annual Return On Equity for 2023 was 20 %, a 115% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -68.4 -1.77 -2.66% 01 Apr 2025 30 Jun 2025
Q1 2025 -74.2 -22.6 -43.7% 01 Jan 2025 31 Mar 2025
Q4 2024 -74.3 -46.7 -169% 01 Oct 2024 31 Dec 2024
Q3 2024 -80 01 Jul 2024 30 Sep 2024
Q2 2024 -66.6 01 Apr 2024 30 Jun 2024
Q1 2024 -51.6 01 Jan 2024 31 Mar 2024
Q4 2023 -27.6 01 Oct 2023 31 Dec 2023

CITIUS ONCOLOGY, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -80 -100 -501% 01 Oct 2023 30 Sep 2024
2023 20 +10.7 +115% 01 Jan 2023 31 Dec 2023
2022 9.3 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.